These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 358445

  • 21. Purification and properties of murine interferon.
    Kawade Y.
    Tex Rep Biol Med; ; 41():219-24. PubMed ID: 6184807
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Preparation of human leukocyte interferon in the presence of tunicamycin and its characterization.
    Chadha KC.
    Methods Enzymol; 1981; 78(Pt A):220-7. PubMed ID: 6173594
    [No Abstract] [Full Text] [Related]

  • 24. [Interferon].
    Jungwirth C, Horak I, Bodo G.
    Zentralbl Bakteriol Orig; 1970; 212(2):370-4. PubMed ID: 5462796
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The use of interferon in viral hepatitis B.
    Desmyter J.
    Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473
    [No Abstract] [Full Text] [Related]

  • 28. Purification of human interferons by antibody affinity chromatography.
    Berg K, Alacam R, Hamilton RD, Heron I.
    Tex Rep Biol Med; 1977; 35():187-92. PubMed ID: 358447
    [Abstract] [Full Text] [Related]

  • 29. Interferons: chemical properties.
    Fantes KH.
    Tex Rep Biol Med; 1977; 41():240-9. PubMed ID: 6184810
    [Abstract] [Full Text] [Related]

  • 30. The role of liver in the catabolism of human alpha- and beta-interferon.
    Bocci V, Pacini A, Bandinelli L, Pessina GP, Muscettola M, Paulesu L.
    J Gen Virol; 1982 Jun; 60(Pt 2):397-400. PubMed ID: 6180128
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antigenic properties of crossprotecting factors in human leukocyte and mouse L cell interferons.
    Paucker K, Dalton BJ.
    Ann N Y Acad Sci; 1980 Jun; 350():332-8. PubMed ID: 6165285
    [No Abstract] [Full Text] [Related]

  • 33. Production, purification and clinical application of human fibroblast interferon.
    Carter WA, Horoszewicz JS.
    Pharmacol Ther; 1980 Jun; 8(2):359-77. PubMed ID: 6155675
    [No Abstract] [Full Text] [Related]

  • 34. Separation of molecular species of human leukocyte and mouse interferons by polynucleotide affinity chromatography.
    Chelbi-Alix MK, Thang MN.
    Methods Enzymol; 1981 Jun; 78(Pt A):582-91. PubMed ID: 6173647
    [No Abstract] [Full Text] [Related]

  • 35. Separation and characterization of molecular components of human leukocyte interferon by concanavalin A-Agarose affinity chromatography.
    Grob PM, Chadha KC.
    Methods Enzymol; 1981 Jun; 78(Pt A):571-6. PubMed ID: 6173645
    [No Abstract] [Full Text] [Related]

  • 36. [Partial purification and characterization of interferon from mouse brain].
    Falcoff R, Fontaine-Brouty D, Falcoff E.
    Ann Inst Pasteur (Paris); 1968 Aug; 115(2):279-87. PubMed ID: 5679338
    [No Abstract] [Full Text] [Related]

  • 37. [Virus inhibiting factors (interferon)].
    Nagano Y.
    Nihon Ishikai Zasshi; 1968 Jun 15; 59(12):1554-60. PubMed ID: 4883343
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interferon nomenclature.
    Nature; 1980 Jul 10; 286(5769):110. PubMed ID: 6157097
    [No Abstract] [Full Text] [Related]

  • 40. Mechanisms of cross-species activity of mammalian interferons.
    Carter WA.
    Pharmacol Ther; 1979 Jul 10; 7(2):245-52. PubMed ID: 392554
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.